Brand
Endo USA, Inc.
5 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Endo USA, Inc. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2025-11-05FDA-DrugClass IIIEverolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-119-91
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
- 2025-11-05FDA-DrugClass IIIEverolimus tablets 10 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-128-91
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
- 2025-11-05FDA-DrugClass IIIEverolimus tablets 7.5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-127-91
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
- 2025-11-05FDA-DrugClass IIIEverolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-125-91
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
- 2025-10-22FDA-DrugClass IIIEverolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 49884-125-91
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Get notified about new Endo USA, Inc. recalls
Free weekly digest. We email when a new federal recall affects Endo USA, Inc. or anything else in your household.
Get the Sunday Brief